{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:55:06Z","timestamp":1787586906195,"version":"build-2736575974"},"reference-count":10,"publisher":"American Society for Clinical Investigation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,30]]},"DOI":"10.1172\/jci131933","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T13:18:39Z","timestamp":1569849519000},"page":"4570-4571","source":"Crossref","is-referenced-by-count":7,"title":["Better living through peptide-conjugated chemistry: next-generation antisense oligonucleotides"],"prefix":"10.1172","volume":"129","author":[{"given":"Elizabeth M.","family":"McNally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Leverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.9","article-title":"Design and analysis of effects of triplet repeat oligonucleotides in cell models for myotonic dystrophy","volume":"2","author":"Gonz\u00e1lez-Barriga","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11362"},{"issue":"11","key":"B3","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1172\/JCI128205","article-title":"Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice","volume":"129","author":"Klein","year":"2019","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.06.036"},{"issue":"2","key":"B5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6020051","article-title":"Cell-penetrating peptides to enhance delivery of oligonucleotide-based therapeutics","volume":"6","author":"McClorey","year":"2018","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-767-5_27"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2017.0682"},{"issue":"Pt A","key":"B8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2016.06.008","article-title":"Peptides for nucleic acid delivery","volume":"106","author":"Lehto","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1220"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz354"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/131933\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T13:32:43Z","timestamp":1691069563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/131933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,1]]},"published-print":{"date-parts":[[2019,11,1]]}},"alternative-id":["10.1172\/JCI131933"],"URL":"https:\/\/doi.org\/10.1172\/jci131933","relation":{},"ISSN":["0021-9738","1558-8238"],"issn-type":[{"value":"0021-9738","type":"print"},{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]}}}